Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2440]

NICE give go ahead for olaparib and enzalutamide, but not abiraterone

NICE give go ahead for olaparib and enzalutamide, but not abiraterone

Building the foundations for cancer genomic analysis for research and clinical diagnostics

Building the foundations for cancer genomic analysis for research and clinical diagnostics

European cancer centres finally united in long-term collaborative partnerships

European cancer centres finally united in long-term collaborative partnerships

Men who forgo aggressive treatment for prostate cancer don't receive appropriate monitoring

Men who forgo aggressive treatment for prostate cancer don't receive appropriate monitoring

Men who forgo aggressive treatment for prostate cancer don't receive appropriate monitoring

Men who forgo aggressive treatment for prostate cancer don't receive appropriate monitoring

Promising drug combination for advanced prostate cancer

Promising drug combination for advanced prostate cancer

Children’s cancer death rates drop by a quarter in 10 years

Children’s cancer death rates drop by a quarter in 10 years

A cocktail of non-toxic chemicals taken from food and vegetables may hold the key to beating untreatable cancers and relapse

A cocktail of non-toxic chemicals taken from food and vegetables may hold the key to beating untreatable cancers...

FDA approves nivolumab to treat advanced form of kidney cancer

FDA approves nivolumab to treat advanced form of kidney cancer

Scientists identify proteins which trigger and drive aggressive prostate cancers

Scientists identify proteins which trigger and drive aggressive prostate cancers

More from ecancer